The global pharmaceutical industry is witnessing unprecedented developments in hyperparathyroidism management, a complex endocrine condition that disrupts calcium homeostasis through excessive parathyroid hormone secretion. This therapeutic area represents a significant opportunity within the broader endocrine disorders market, with the Hyperparathyroidism Treatment Market...